Final phase trials for MDMA-assisted psychotherapy to treat PTSD

After decades of research and advocacy, the Multidisciplinary Association for Psychedelic Studies (MAPS), led by Rick Doblin, has moved into the final stages of its work pushing for MDMA-assisted psychotherapy treatment of post-traumatic stress disorder (PTSD). MAPS and the FDA have agreed on the design of the Phase III trials and, if successful, the drug could be available as a legally prescribed treatment for PTSD sufferers as soon as 2021.
First synthesized in 1912, 3,4-Methylenedioxymethamphetamine (MDMA) was rediscovered in the mid-1970s by pioneering psychopharmacologist Alexander Shulgin. Informal self-trials by Shulgin and his colleagues identified the drug as compellingly psychoactive and possibly useful for psychotherapy.

Read from Original Source

Entheogen-assisted Healing

Taking entheogens can be like air travel: people do it all the time, it’s usually fine, but when it’s not fine, it’s sometimes very bad. We’ve been there. And that’s where an experienced GUIDE can make the difference in the outcome.
I’m available by phone if you or someone you know wants to ask questions of ANY nature. Use this link to schedule a call HERE.